|
CYB561D1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.47939999999947E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.213900E-04 |
| Normal-vs-Stage2 |
3.091800E-01 |
| Normal-vs-Stage3 |
4.51639999998754E-06 |
| Normal-vs-Stage4 |
6.72670000034792E-07 |
| Stage1-vs-Stage2 |
1.914000E-02 |
| Stage1-vs-Stage3 |
1.049770E-01 |
| Stage1-vs-Stage4 |
1.536250E-02 |
| Stage2-vs-Stage3 |
1.123630E-03 |
| Stage2-vs-Stage4 |
1.043510E-04 |
| Stage3-vs-Stage4 |
2.670800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.9977999999865E-06 |
| Normal-vs-AfricanAmerican |
6.961400E-04 |
| Normal-vs-Asian |
3.557500E-02 |
| Caucasian-vs-AfricanAmerican |
4.026000E-01 |
| Caucasian-vs-Asian |
5.996000E-02 |
| AfricanAmerican-vs-Asian |
5.068100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.23200000000801E-05 |
| Normal-vs-Female |
6.31799999999405E-05 |
| Male-vs-Female |
5.178000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.643000E-04 |
| Normal-vs-Age(41-60Yrs) |
4.992400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.86471999999993E-05 |
| Normal-vs-Age(81-100Yrs) |
2.435800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.788800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.355600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.342580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.305200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.472160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.683200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.11610000000673E-05 |
| Classical-VS-Follicular |
1.431420E-01 |
| Classical-VS-Other |
3.102200E-01 |
| Classical-VS-Normal |
1.218870E-04 |
| Tall-VS-Follicular |
3.48900000002317E-06 |
| Tall-VS-Other |
5.735200E-01 |
| Tall-VS-Normal |
2.60199994883692E-09 |
| Follicular-VS-Other |
1.623970E-01 |
| Follicular-VS-Normal |
2.446300E-02 |
| Other-VS-Normal |
1.595870E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.238600E-03 |
| Normal-vs-N1 |
7.41669999859695E-08 |
| N0-vs-N1 |
3.190300E-04 |
|
|
